A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia
ConditionFunctional Dyspepsia
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age19-75
SponsorDong-A ST Co., Ltd.
About this trial
This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia
Eligibility criteria
Qualifiers
Men or women aged 19 to 75 years, inclusive
Subjects diagnosed with functional dyspepsia according to the Rome IV criteria
Subjects with at least three symptoms rated as moderate or severe on the Gastrointestinal Symptom Score(GIS)
Subjects who voluntarily signed a consent form
Disqualifiers
Subjects with a history of organic diseases that could cause dyspepsia
Subjects with hypersensitivity to investigational drugs and similar drugs
Pregnant or breastfeeding women
Trial design
Treatments tested in this trial
- DA-9701
- DA-9701-R
- DA-9701 Placebo
- DA-9701-R Placebo
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov